Resources

How has the pandemic affected the incidence of type 2 diabetes and other conditions such as Hyperosmolar Hyperglycemic Syndrome (HHS) within the younger population?

With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?

Male, 72 years of age, type 2, insulin-requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of the workday, glucose elevated much higher than the reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy....

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.

Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19. 

Study finds type 1 diabetes may account for 8% of diabetes cases in young adults.

American Diabetes Association symposium presents new phase 3 clinical trials of SURPASS-3 and SURPASS-5. 

Researchers assess the safety of intranasal insulin as a treatment for type 2 diabetes-associated cognitive impairment in aging adult populations.